Cargando…

Targeted Perturb-seq enables genome-scale genetic screens in single cells

The transcriptome contains rich information on molecular, cellular, and organismal phenotypes. However, experimental and statistical limitations constrain sensitivity and throughput of genetic screening with single-cell transcriptomics readout. To overcome these limitations, we introduce targeted Pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Schraivogel, Daniel, Gschwind, Andreas R., Milbank, Jennifer H., Leonce, Daniel R., Jakob, Petra, Mathur, Lukas, Korbel, Jan O., Merten, Christoph, Velten, Lars, Steinmetz, Lars M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610614/
https://www.ncbi.nlm.nih.gov/pubmed/32483332
http://dx.doi.org/10.1038/s41592-020-0837-5
Descripción
Sumario:The transcriptome contains rich information on molecular, cellular, and organismal phenotypes. However, experimental and statistical limitations constrain sensitivity and throughput of genetic screening with single-cell transcriptomics readout. To overcome these limitations, we introduce targeted Perturb-seq (TAP-seq), a sensitive, inexpensive, and platform-independent method focusing single-cell RNA-seq coverage on genes of interest, thereby increasing the sensitivity and scale of genetic screens by orders of magnitude. TAP-seq permits routine analysis of 1,000s of CRISPR-mediated perturbations within a single experiment, detects weak effects and lowly expressed genes, and decreases sequencing requirements up to 50-fold. We apply TAP-seq to generate perturbation-based enhancer-target gene maps for 1,778 enhancers within 2.5% of the human genome. Thereby, we show that enhancer-target association is jointly determined by 3D contact frequency and epigenetic states, allowing accurate prediction of enhancer targets throughout the genome. In addition, we demonstrate that TAP-seq can identify cell subtypes with only 100 sequencing reads per cell.